Logos Global Management LP [Rocket]

Date	Name	Symbol	Type	Security	Shares	Price	Value	Ownership	Reported
06/21/2021	Verve Therapeutics, Inc.		Purchase	Common Stock	370k	$19.00	$7M		06/21/2021
06/21/2021	Verve Therapeutics, Inc.		Conversion	Series B Preferred Stock	4.1M	$0.00	$0	See Footnotes	06/21/2021
06/21/2021	Verve Therapeutics, Inc.		Conversion	Common Stock	443.3k	$0.00	$0	See Footnotes	06/21/2021
10/30/2020	Eledon Pharmaceuticals, Inc.	NVUS	Purchase	Common Stock	9.1k	$25.55	$232.5k	See Notes 1 and 2	10/30/2020
10/30/2020	Eledon Pharmaceuticals, Inc.	NVUS	Purchase	Common Stock	15k	$26.17	$392.6k	See Notes 1 and 2	10/30/2020
10/30/2020	Eledon Pharmaceuticals, Inc.	NVUS	Sale	Common Stock	27	$27.02	$729.5	See Notes 1 and 2	10/30/2020
10/30/2020	Eledon Pharmaceuticals, Inc.	NVUS	Purchase	Common Stock	12.9k	$25.88	$334.9k	See Notes 1 and 2	10/30/2020
10/30/2020	Eledon Pharmaceuticals, Inc.	NVUS	Sale	Common Stock	12.9k	$26.64	$344.8k	See Notes 1 and 2	10/30/2020
10/30/2020	Eledon Pharmaceuticals, Inc.	NVUS	Purchase	Common Stock	15k	$26.48	$397.2k	See Notes 1 and 2	10/30/2020
10/30/2020	Eledon Pharmaceuticals, Inc.	NVUS	Purchase	Common Stock	4k	$25.97	$103.9k	See Notes 1 and 2	10/30/2020
10/30/2020	Eledon Pharmaceuticals, Inc.	NVUS	Purchase	Common Stock	31k	$24.53	$760.4k	See Notes 1 and 2	10/30/2020
10/30/2020	Eledon Pharmaceuticals, Inc.	NVUS	Purchase	Common Stock	5k	$24.03	$120.2k	See Notes 1 and 2	10/30/2020
09/21/2020	Dyne Therapeutics, Inc.		Conversion	Series B Preferred Stock	2.7M	$0.00	$0	See footnotes	09/21/2020
09/21/2020	Dyne Therapeutics, Inc.		Purchase	Common Stock	700k	$19.00	$13.3M	See footnotes	09/21/2020
09/21/2020	Dyne Therapeutics, Inc.		Conversion	Common Stock	804.4k	$0.00	$0	See footnotes	09/21/2020